About Kraig Biocraft Laboratories Inc
- Industry: Chemicals
- Exchange: OTC MARKETS
- Country: US
- Website: https://www.kraiglabs.com/
Frequently Asked Questions
What is the 52-week range for KBLB?
The 52-week high is $0.16 and the 52-week low is $0.065.
What is the P/E ratio for KBLB?
The P/E ratio data is currently unavailable.
What is the dividend yield for KBLB?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -61.55%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -208.51%.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Latest KBLB News
Kraig Labs Ships First Commercial Spider Silk Order for Performance Textile Development
Kraig Biocraft Laboratories has shipped its first commercial recombinant spider silk yarn order to a globally recognized performance sports brand, moving its material into a customer product-development program for the first time. Key Investor TakeawaysKraig Biocraft Laboratories (USOTC:KBLB) shipped its first commercial spider silk order to an unnamed global performance sports brand.
Kraig Labs Opens the Global Market for Its Spider Silk with Historic Multi-Kilogram Order
First commercial spider silk yarn shipment for a global performance sports brand marks a milestone alongside record production and Project Atlas advancesHouston, Texas--(Newsfile Corp. - September 29, 2026) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has shipped a historic multi-kilogram order of recombinant spider silk yarn for a globally recognized performance sports brand, marking the Company's first remunerated commercial yarn shipment.The custom-engineered yarn was produced to fulfill
Kraig Biocraft Laboratories Ships its First Commercial Spider Silk Yarn Order for Performance Sports Brand
Milestone Marks Recombinant Spider Silk’s Move from Scaled Production to a First-of-Its-Kind Performance TextileANN ARBOR, Mich., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig's”), a world leader in spider silk technology*, today announced the shipment of its first commercial order of recombinant spider silk yarn. The custom-engineered yarn was produced to fulfill a purchase commitment from a globally recognized perform
Kraig Biocraft Laboratories Completes Project Atlas Gene Library for Next-Generation Spider Silk Development
Kraig Biocraft Laboratories (USOTC:KBLB) has completed the foundational Project Atlas Gene Library after integrating all planned transgenes into living commercial silkworm hosts, moving the research program into breeding and evaluation of more than 200 potential genetic configurations. Key Investor TakeawaysKraig Biocraft Laboratories (USOTC:KBLB) said every planned Project Atlas transgene has now been integrated into living commercial silkworm hosts.
Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library
Kraig Labs Project Atlas Researcher Kraig Labs Project Atlas Researcher oversees latest crop of Atlas transgenics ANN ARBOR, Mich., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a major milestone for Project Atlas, the Company's most ambitious genetic engineering initiative to date. The Company has successfully integrated every planned Project Atlas transge
Kraig Biocraft Laboratories Highlights Spider Silk Fashion Opportunity as Production Advances
Kraig Biocraft Laboratories is positioning its recombinant spider silk for potential fashion and textile applications after reporting production of approximately 3. 2 metric tons of cocoons in a single production cycle earlier this year.
As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers
Fashion industry shift puts new focus on bio-based and innovative textiles as Kraig Labs scales recombinant spider silk for potential luxury and performance applicationsANN ARBOR, Mich., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today highlighted the growing opportunity for advanced biomaterials in fashion as New York Fashion Week begins. The Council of Fashion Designe
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
Feature Explores the Real Biology Behind Recombinant Spider Silk and the Scientific Case for Kraig Labs' Production PlatformANN ARBOR, Mich., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today highlighted recent coverage by Tech Times examining the scientific gap between fictional biology and real-world advances in recombinant spider silk production. The August 31, 2026 T